ロピニロールに対する薬物動態データ

Same author

Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.

Neurology·2005

Same author

A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy.

Seizure·2005

Same author

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

Neurology·2000

Same author

Interferon beta: the current position.

British journal of hospital medicine·1997

Same author

Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions.

BMJ (Clinical research ed.)·1996

Same author

The evolution and profile of dementia in Parkinson's disease.

Advances in neurology·1996

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

ロピニロールに対する薬物動態データ

関連する概念動画

Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.

A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy.

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

Interferon beta: the current position.

Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions.

The evolution and profile of dementia in Parkinson's disease.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

ロピニロールに対する薬物動態データ

関連する概念動画

関連記事

Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.

A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy.

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

Interferon beta: the current position.

Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions.

The evolution and profile of dementia in Parkinson's disease.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.